马冰磊

一、基本情况

医学博士，主治医师，出诊时间与地点：黄埔院区 周一下午、周二 周四上午

二、教育及工作经历

2010年-2015年就读于中山大学，获临床医学学士学位。

2015年-2021年就读于北京大学，获外科学博士学位。

2021年起于中山大学肿瘤防治中心泌尿外科工作至今，任主治医师、博士后、助理研究员。

2025年9月至2026年9月于香港大学玛丽医院访问学习，任香港大学外科学系名誉研究助理、香港大学玛丽医院访问学者。

三、学术兼职

广东省抗癌学会肿瘤肾脏病学专业委员会 委员

广东省抗癌协会泌尿生殖系肿瘤专业委员会 成员

中国抗癌协会中西整合肾癌专业委员会 成员

四、主持科研项目

ANAPC15缺失抑制DNA损伤修复促进肿瘤放疗敏感性的机制探究，2023广州市基础与应用基础研究专题，已结题。

五、代表性论著

1. Karimzadeh, I.; Kane-Gill, S.L.; Ma, B. Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies. Antibiotics 2025, 14, 1138. https://doi.org/10.3390/antibiotics14111138.

2. Hou, Y.; Zhang, Q.; Ma, B. Kidney, Prostate, and Bladder Cancer Burden Attributable to Tobacco Smoke Exposure in BRICS Countries from 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease Study. Healthcare 2025, 13, 3082. doi: 10.3390/healthcare13233082.

3. Ma BL, Ma C, Long X, Jiang L. Stromal reprogramming in urachal cancer: Fibroblast activation protein and collagen remodeling drive immune-suppressive niches and immunotherapy resistance. Int Immunopharmacol. 2025 Oct 10;163:115204. doi: 10.1016/j.intimp.2025.115204.

4. Huang T, Peng Y, Liu R, Ma BL, Chen J, Wei W, Zhong W, Liu Y, Guo S, Han H, Zhou F, Zhang Z, He L, Dong P. Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy. Int Immunopharmacol. 2024 Dec 5;142(Pt B):113106. doi: 10.1016/j.intimp.2024.113106.

5. Xu B, Ma BL, Peng YJ, Zhang Q. Learning Curve of an Innovative "3-Port" Laparoscopic Radical Prostatectomy: A Single-Center Analysis from 2016 to 2019. Urol Int. 2021;105(5-6):402-407. doi: 10.1159/000514390.

6. Ma BL, Yao L, Fan Y, Wang Y, Meng YS, Zhang Q, He ZS, Jin J, Zhou LQ. Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer. Cancer Manag Res. 2019 May 10;11:4143-4151. doi: 10.2147/CMAR.S196378.

7. Ma BL, Yao L, Yu W, Wang Y, Song HF, Zhang ZN, Lu SM, Zhang Q, He ZS, Jin J, Zhou LQ. The Institute of Urology, Peking University prostatectomy score: a simple preoperative classification of prostate cancer for predicting surgical difficulty and risk. Asian J Androl. 2018 Nov-Dec;20(6):581-586. doi: 10.4103/aja.aja_39_18.

8. Gan Y, Cao C, Li A, Song H, Kuang G, Ma B, Zhang Q, Zhang Q. Silencing of the TRIM58 Gene by Aberrant Promoter Methylation is Associated with a Poor Patient Outcome and Promotes Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma. Front Mol Biosci. 2021 Mar 16;8:655126. doi: 10.3389/fmolb.2021.655126.

9. Liang L, Song H, Ma B, Zhang Z, Zhu K, Li Q, Zhou C, Li A, Liu J, Zhang Q, Zhu S, Zhang Q. Renal Ewing's sarcoma/primitive neuroectodermal tumor (PNET): a case series of 7 patients and literature review. Transl Androl Urol. 2021 Feb;10(2):548-554. doi: 10.21037/tau-20-1122.

10. Xu B, Peng YJ, Ma BL, Cheng SD. Aberrant methylation of the 16q23.1 tumor suppressor gene ADAMTS18 promotes tumorigenesis and progression of clear cell renal cell carcinoma. Genes Genomics. 2021 Feb;43(2):123-131. doi: 10.1007/s13258-021-01036-9.

11. Zhang Z, Li Q, Wang F, Ma B, Meng Y, Zhang Q. Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma. Front Genet. 2021 Jun 14;12:606816. doi: 10.3389/fgene.2021.606816.

12. Li A, Gan Y, Cao C, Ma B, Zhang Q, Zhang Q, Yao L. Transcriptome-Wide Map of N6-Methyladenosine Methylome Profiling in Human Bladder Cancer. Front Oncol. 2021 Nov 15;11:717622. doi: 10.3389/fonc.2021.717622.

13. Yao L, Zhang Q, Li A, Ma B, Zhang Z, Liu J, Liang L, Zhu S, Gan Y, Zhang Q. Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems. Front Mol Biosci. 2020 Dec 9;7:617600. doi: 10.3389/fmolb.2020.617600.

14. Zhu K, Song H, Zhang Z, Ma B, Bao X, Zhang Q, Jin J. Acute kidney injury in solitary kidney patients after partial nephrectomy: incidence, risk factors and prediction. Transl Androl Urol. 2020 Jun;9(3):1232-1243. doi: 10.21037/tau.2020.03.45.

15. Song H, Kuang G, Zhang Z, Ma B, Jin J, Zhang Q. The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis. J Cancer. 2019 Jan 1;10(2):479-487. doi: 10.7150/jca.26989.

16. Song H, Xu B, Luo C, Zhang Z, Ma B, Jin J, Zhang Q. The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study. Cancer Manag Res. 2019 Aug 9;11:7567-7575. doi: 10.2147/CMAR.S209418.

17. Zhang ZN, Luo C, Xu B, Song HF, Ma BL, Zhang Q. Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy. Cancer Manag Res. 2018 Oct 16;10:4671-4677. doi: 10.2147/CMAR.S175869.

更新时间：2026.8.28